P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Urheber
-
Zolla-Pazner, S.
- Beteiligte Personen und Organisationen
-
Wrin, T.
Seaman, MS
Yu, X.
Wood, B.
Self, S.
Hioe, CE
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-P395
- URN
-
urn:nbn:de:1111-201608079126
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:55 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zolla-Pazner, S.
- Wrin, T.
- Seaman, MS
- Yu, X.
- Wood, B.
- Self, S.
- Hioe, CE
- SpringerLink (Online service)
Ähnliche Objekte (12)
A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
Broad neutralizing activity of a human monoclonal antibody against H7N9 strains from 2013 to 2017
Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Construction and characterization of neutralizing antibody fragments for efficient access to V3 epitope
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies
Characterization of a major neutralizing epitope on the yellow fever virus envelope protein using human recombinant monoclonal antibody fragments generated by phage display
A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
Broad neutralizing activity of a human monoclonal antibody against H7N9 strains from 2013 to 2017
Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Construction and characterization of neutralizing antibody fragments for efficient access to V3 epitope
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies
Characterization of a major neutralizing epitope on the yellow fever virus envelope protein using human recombinant monoclonal antibody fragments generated by phage display
A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
Broad neutralizing activity of a human monoclonal antibody against H7N9 strains from 2013 to 2017
Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Construction and characterization of neutralizing antibody fragments for efficient access to V3 epitope
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies
Characterization of a major neutralizing epitope on the yellow fever virus envelope protein using human recombinant monoclonal antibody fragments generated by phage display